A bold step towards a cervical cancer-free future
Context:
India’s interim Union Budget 2024-25 prioritizes women’s health by advocating for the vaccination of girls against cervical cancer.
- The global ’90-70-90′ targets set by the World Health Organization aim to combat cervical cancer through vaccination, screening, and treatment.
Relevance:
GS-02 ( Health)
Main highlights:
- Success stories from countries like Scotland, Australia, and Rwanda highlight the efficacy of HPV vaccination in reducing cervical cancer incidence.
- India’s indigenous quadrivalent vaccine, Cervavac, and Sikkim’s successful vaccination campaign serve as examples of progress in combating cervical cancer.
- Challenges such as vaccine hesitancy and equitable access need to be addressed to ensure the success of HPV vaccination programs in India.
Dimensions of the Article:
- Cervical Cancer Overview
- HPV Strain Varieties
- Global Efforts Against Cervical Cancer
- India’s Initiative in Women’s Health
- Cervavac Overview
- Success Stories and Lessons Learned
- Challenges and Opportunities
Cervical Cancer Overview:
- Cervical cancer arises in the cervix of women and ranks as the fourth most prevalent cancer type worldwide, standing as the second most common among Indian women.
- Effective primary prevention strategies such as HPV vaccination and secondary prevention methods like screening for and treating precancerous lesions have the potential to avert the majority of cervical cancer cases.
- Timely detection and appropriate management render cervical cancer highly treatable when diagnosed early.
- India bears a substantial burden of cervical cancer, accounting for approximately one-fifth of global cases, with around 125,000 new cases and 75,000 deaths annually.
HPV Strain Varieties:
- Persistent infections with specific high-risk HPV strains account for nearly 85% of all cervical cancers.
- Among the identified oncogenic HPV types, comprising at least 14 strains with cancer-causing potential, HPV 16 and 18 are deemed the most carcinogenic, responsible for approximately 70% of cervical cancer cases worldwide.
Global Efforts Against Cervical Cancer:
- The World Health Organization’s ’90-70-90′ targets represent a concerted effort to combat cervical cancer globally.
- These targets emphasize the importance of HPV vaccination, cervical cancer screening, and treatment to reduce the burden of the disease.
- Countries like Scotland, Australia, and Rwanda have witnessed significant declines in cervical cancer incidence through successful HPV vaccination campaigns, demonstrating the effectiveness of preventive measures.
India’s Initiative in Women’s Health:
- India’s interim Union Budget 2024-25 highlights the government’s commitment to women’s health by advocating for the vaccination of girls against cervical cancer.
- Despite being the second most common cancer among women in India, cervical cancer remains a preventable disease with the implementation of HPV vaccination programs.
- The development of Cervavac, an indigenous quadrivalent vaccine, reflects India’s efforts to ensure accessibility and affordability in combating cervical cancer.
Cervavac Overview:
- It is developed by the Serum Institute of India in collaboration with the Department of Biotechnology (DBT) in Pune.
- The project commenced under the leadership of Dr. M K Bhan, the former secretary of DBT, in 2011.
- Market authorization of the same is granted by the Drug Controller General of India on July 12 this year.
- Unique Features:
- Administered in two doses, with data indicating long-lasting antibody development for up to six or seven years.
- Unlikely Covid vaccines, this does not require booster shots.
- Expected to be significantly cheaper than existing HPV vaccines, with an estimated cost of Rs 200 to 400 per dose.
Challenges and Opportunities:
- However, challenges such as vaccine hesitancy and equitable access persist in the implementation of HPV vaccination programs.
- Addressing misinformation and strengthening healthcare infrastructure are crucial steps in overcoming these hurdles.
- India’s rollout of the U-WIN portal, akin to Co-WIN for COVID-19 vaccination, aims to streamline vaccination efforts and improve responsiveness.
- Collaborations between government agencies, healthcare providers, and civil society organizations are essential in building trust and ensuring the success of HPV vaccination programs.
Way Forward:
- India’s inclusion of HPV vaccination in the interim Union Budget 2024-25 marks a significant step towards advancing women’s health.
- By leveraging its experiences in vaccine distribution and community engagement, India can build a robust HPV vaccination program that addresses the unique challenges of cervical cancer prevention.
- Continued investment in public health infrastructure and education is key to overcoming barriers and achieving widespread vaccination coverage.
Related Posts
Current Affairs Quiz – 22nd March, 2022
Posted on
